Gainers
- Cumberland CPIX stock rose 30.3% to $2.15 during Monday's pre-market session. The market value of their outstanding shares is at $30.9 million. As per the press release, Q1 earnings came out 4 days ago.
- Aligos Therapeutics ALGS shares increased by 27.52% to $1.39. The market value of their outstanding shares is at $59.6 million.
- Sarepta Therapeutics SRPT stock increased by 25.87% to $151.3. The company's market cap stands at $14.0 billion.
- CEL-SCI CVM stock moved upwards by 15.41% to $2.77. The market value of their outstanding shares is at $123.4 million. As per the news, the Q2 earnings report came out yesterday.
- Cadrenal Therapeutics CVKD shares rose 14.12% to $1.6. The company's market cap stands at $18.5 million.
- Tivic Health Systems TIVC shares increased by 13.49% to $0.2. The market value of their outstanding shares is at $5.9 million. As per the news, the Q1 earnings report came out today.
Losers
- Athenex ATNX stock declined by 53.5% to $0.53 during Monday's pre-market session. The market value of their outstanding shares is at $4.5 million.
- Larimar Therapeutics LRMR stock declined by 20.95% to $4.0. The market value of their outstanding shares is at $173.0 million.
- NovaBay Pharmaceuticals NBY stock declined by 20.07% to $0.78. The market value of their outstanding shares is at $1.5 million. The company's, Q1 earnings came out 2 days ago.
- Dermata Therapeutics DRMA shares fell 11.88% to $2.3. The market value of their outstanding shares is at $1.9 million. As per the press release, Q1 earnings came out 2 days ago.
- Meihua Intl Medical Techs MHUA stock decreased by 11.43% to $3.72. The market value of their outstanding shares is at $89.0 million.
- Genelux GNLX shares decreased by 9.81% to $23.0. The company's market cap stands at $564.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in